FI960367A0 - New dialkoxypyridinylbenzimidazole derivatives - Google Patents

New dialkoxypyridinylbenzimidazole derivatives

Info

Publication number
FI960367A0
FI960367A0 FI960367A FI960367A FI960367A0 FI 960367 A0 FI960367 A0 FI 960367A0 FI 960367 A FI960367 A FI 960367A FI 960367 A FI960367 A FI 960367A FI 960367 A0 FI960367 A0 FI 960367A0
Authority
FI
Finland
Prior art keywords
dialkoxypyridinylbenzimidazole
derivatives
new
new dialkoxypyridinylbenzimidazole
dialkoxypyridinylbenzimidazole derivatives
Prior art date
Application number
FI960367A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI960367A (en
Inventor
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Unge Pet Oskar Sverker Von
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI960367A publication Critical patent/FI960367A/en
Publication of FI960367A0 publication Critical patent/FI960367A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI960367A 1994-05-27 1996-01-26 New dialkoxypyridinylbenzimidazole derivatives FI960367A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (2)

Publication Number Publication Date
FI960367A FI960367A (en) 1996-01-26
FI960367A0 true FI960367A0 (en) 1996-01-26

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960367A FI960367A0 (en) 1994-05-27 1996-01-26 New dialkoxypyridinylbenzimidazole derivatives

Country Status (18)

Country Link
EP (1) EP0712401A1 (en)
JP (1) JPH09504557A (en)
CN (1) CN1128997A (en)
AU (1) AU2633095A (en)
BR (1) BR9506235A (en)
CA (1) CA2166988A1 (en)
CZ (1) CZ24396A3 (en)
EE (1) EE9600011A (en)
FI (1) FI960367A0 (en)
HU (1) HU9600005D0 (en)
IL (1) IL113604A0 (en)
IS (1) IS4321A (en)
MA (1) MA23563A1 (en)
NO (1) NO960268L (en)
PL (1) PL312692A1 (en)
TN (1) TNSN95062A1 (en)
WO (1) WO1995032959A1 (en)
ZA (1) ZA954125B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
ES2222754T3 (en) * 1998-11-18 2005-02-01 Astrazeneca Ab IMPROVED CHEMICAL PROCEDURE, AND PHARMACEUTICAL FORMULATION.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CN101980700A (en) 2008-02-20 2011-02-23 密苏里大学董事会 Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
UA115139C2 (en) 2011-12-28 2017-09-25 Поузен Інк. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69131627T2 (en) * 1990-06-20 2000-04-27 Astra Ab Soedertaelje DIALKOXYPYRIDINYLBENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION AND THEIR PHARMACEUTICAL USE
DE4035455A1 (en) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab ENANTIOMER SEPARATION

Also Published As

Publication number Publication date
WO1995032959A1 (en) 1995-12-07
BR9506235A (en) 1997-08-12
ZA954125B (en) 1995-11-27
CN1128997A (en) 1996-08-14
PL312692A1 (en) 1996-05-13
EE9600011A (en) 1996-04-15
EP0712401A1 (en) 1996-05-22
IS4321A (en) 1996-01-17
NO960268D0 (en) 1996-01-23
HU9600005D0 (en) 1996-03-28
CA2166988A1 (en) 1995-12-07
MA23563A1 (en) 1995-12-31
AU2633095A (en) 1995-12-21
NO960268L (en) 1996-01-23
JPH09504557A (en) 1997-05-06
CZ24396A3 (en) 1996-06-12
FI960367A (en) 1996-01-26
TNSN95062A1 (en) 1996-02-06
IL113604A0 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
NO952854D0 (en) 1-arylpyrimidin derivatives
DE59508427D1 (en) 3-ARYL-4-HYDROXY-DELTA 3 -DIHYDROTHIOPHENONE DERIVATIVES
FI972970A0 (en) New compounds
FI20030162A (en) New compounds
ATE323682T1 (en) ARYL-PYRIMIDINE DERIVATIVES
ATE261942T1 (en) 6-PHENYLPYRIDINE DERIVATIVES
FI955927A (en) Substituted 1H-imidazoles
IS4800A (en) New 19-nor-pregnene derivatives
NO981946D0 (en) Imidazoquinazolin derivatives
DE69534718D1 (en) SUBSTITUTED 9-ALKYLADENINE
DE69732576D1 (en) TETRAHYDROBENZINDOLON DERIVATIVES
DE69430587D1 (en) PYRIMIDINE-ACYCLONUKLEOSID DERIVATIVES
BR9509793A (en) Thiophenene derivatives
FI960367A0 (en) New dialkoxypyridinylbenzimidazole derivatives
IS5026A (en) 2-methoxyphenylpiperazine derivatives
DE69527786D1 (en) DIAMINOMETHYLIDES DERIVATIVES
DE59509209D1 (en) DIPHENYLOXAZOLINE DERIVATIVES
BR9509559A (en) Substituted azolylulsolfonylphenyluracils
FI974001A0 (en) Nya methylenebisphosphonium derivatives
DE69510792D1 (en) NAPHTOCHINONE DERIVATIVES
BR9509877A (en) New pyrimidinyloxy-and pyridimidinylamino-ethylphenyl-dioxolane derivatives
DE69515498D1 (en) NAPHTHYRIDINE DERIVATIVES
NO993024D0 (en) The polysaccharide-peptide derivatives
FI960366A (en) New substituted benzimidazoles
BR9506613A (en) Phenylthiooxazolines derivatives

Legal Events

Date Code Title Description
FD Application lapsed